Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...

With about 190,000 people in the UK living with the disease and 10,000 diagnosed annually, the early treatment method could ...

For patients newly diagnosed with Crohn’s disease, initiating anti-TNF therapy early led to better outcomes and lower overall costs than beginning with conventional treatments and escalating later.

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

With an increasing number of available drugs along with a focus on early treatment regimens and drug sequencing in Crohn's disease, data from prospective, well designed studies to guide on drug choice ...

Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

Crohn’s disease is a type of inflammatory bowl disease (IBD) that can take place anywhere in the digestive tract. According to the Centers for Disease Control and Prevention (CDC), prevalence of IBD ...

Crohn’s Disease can affect any part of the gastrointestinal tract, but most commonly targets the terminal ileum and proximal colon. A key characteristic of Crohn’s is transmural involvement, meaning ...

Your gut harbors trillions of microbes which live in precarious harmony with your immune system. When that harmony is upset, ...

Crohn’s colitis is a type of Crohn’s disease that only affects the colon, or large intestine. It differs from other types of ...

According to the Crohn’s and Colitis Foundation, nearly 1 in every 100 Americans are diagnosed with inflammatory bowel disease, or IBD. There are two types, ulcerative colitis and Crohn’s disease, and ...

Crohn's disease is a chronic inflammatory bowel disease (IBD) that affects the digestive tract, often causing abdominal pain, persistent diarrhea, rectal bleeding, weight loss, and fatigue during ...